‘Trojan horse’ drug sneaks into tumour and kills it from inside

A “TROJAN horse” drug which attacks tumour cells from within may offer new hope to cancer patients with few options left, doctors say.

The new treatment has generated promising results in people with six different cancer types including cervical, bladder, ovarian and lung, early trial results published in journal ‘The Lancet Oncology’ show.

The drug – tisotumab vedotin (TV) – was tested on patients with advanced cancers which had stopped responding to standard treatments, and caused

Six types of cancer cells responded to the treatmentsome tumours to shrink.“Its mechanism of action is completely novel – it acts like a Trojan horse to sneak into cancer cells and kill them from the inside,” lead author Professor Johann de Bono said.